BioTek Synergy™ Neo2 Granted Cisbio HTRF® Certification
9 Aug 2015BioTek Instruments' new Synergy Neo2 Multi-Mode Reader has received its Cisbio HTRF® certification.
Synergy Neo2 joins several other previously certified readers from BioTek’s current lineup – Cytation™ 5, Cytation 3, Synergy H1 and Synergy 2. Cisbio and BioTek have a long history of collaborative development, most recently in cancer research where the companies' technologies were combined to present an easy-to-use method for assessing target-based and phenotypic effects of new, potential anti-metastatic drugs.
Synergy Neo2 is designed for speed and ultra high performance, incorporating BioTek's patented Hybrid Technology™, with its independent optical paths that ensure uncompromised performance in all detection modes. Continuously variable bandwidth quadruple monochromators, sensitive high transmission filter-based optics, and up to 4 PMTs provide ultra-fast measurements with excellent results.
Related Products
Request Quote for All Products
Agilent BioTek Synergy Neo2 Hybrid Multimode Reader
Agilent TechnologiesAgilent BioTek Synergy Neo2 multimode microplate reader features proprietary Hybrid Technology, with independent optical paths that ensure excellent performance in all detection modes. Variable bandwidth quad monochromators, sensitive high transmission filter-based optics, laser TRF, and up to 4 PMTs provide ultrafast measurements.